Reprint

Chagas Disease

Edited by
August 2021
150 pages
  • ISBN978-3-0365-1248-8 (Hardback)
  • ISBN978-3-0365-1249-5 (PDF)

This is a Reprint of the Special Issue Chagas Disease that was published in

Biology & Life Sciences
Medicine & Pharmacology
Public Health & Healthcare
Summary

Despite being described for the first time more than 110 years ago, Chagas disease (caused by the parasite Trypanosoma cruzi) persists as one of the most neglected tropical diseases. This persistent neglect of those affected by this disease is evidenced by the ongoing scientific evidence gaps, the difficulty of incorporating new diagnostic and treatment technologies into the market, and public health failures to ensure timely access to diagnosis and treatment associated with the development of consistent surveillance and control actions. As a result, there is a high burden of morbidity and mortality, and poor quality of life, poverty, stigma, and a fear of death persist for affected people, both in endemic areas in Latin America, and in non-endemic areas. This book spans a variety of disciplines and contributes significantly to reducing the gap in scientific knowledge on Chagas disease, towards achieving the Sustainable Development Goals by 2030.

Format
  • Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
Chagas disease; neglected tropical diseases; migration; healthcare rights; mucosal leishmaniasis; Chagas disease; co-infection; antimoniate therapy; Chagas disease; cardiomyopathy; myocardial fibrosis; myocardial sympathetic denervation; inflammation; sudden death; cardiac magnetic resonance; radionuclide imaging; SPECT-CT; PET-CT; Chagas disease; heart disease; electrocardiogram; disease progression; Chagas disease; stroke; risk assessment; Trypanosoma cruzi; Triatoma infestans; Chagas disease; parasite prevalence; coprophagy; Chagas disease; human illness; neglected tropical disease; global financing; annual funding; investments; Chagas disease; disease notification; public policy; neglected topical diseases; healthcare access; n/a; chagasic cardiomyopathy; heart transplantation; Chagas disease reactivation; cardiac allograft rejection; treatment of reactivation; Trypanosoma cruzi; genome; parasite; neglected diseases; chagasic cardiomyopathy; heart transplant; chagas disease reactivation; Chagas disease; Cohort studies; Neglected diseases; Trypanosoma cruzi; Dynamic programming; Chagas disease; cost of illness; premature; efficiency; organizational; life expectancy; Chagas disease; American trypanosomiasis; Trypanosoma cruzi infection; neglected tropical disease; public health; epidemiology; prevention and control; surveillance; clinical research; One Health

Related Books